SYS-CON MEDIA Authors: Bob Gourley, Sandi Mappic, Eric Brown, RealWire News Distribution, Kevin Benedict

News Feed Item

"Nanofics" Global Nanocoating Licensees for Handheld Electronic Devices, Announced by Europlasma NV

OUDENAARDE, Belgium, November 19, 2012 /PRNewswire/ --

- List of licensees and sub-licensees include Liquipel, Vita Group, Hydrowarriors, Fung Yu Group, Aquacoat and Intego Capital LLC.

Belgium based Europlasma NV, a world leader in the design and manufacturing of low pressure plasma equipment since 1993 would like to publicly announce its current list of "Nanofics" patented and patent pending nanocoating technology licensees for retail of handheld electronic devices.

"Nanofics" refers to nano-scaled functionalization into the core of complex shaped materials and products. It is Europlasma's patented and patent pending nanocoating technology platform, first developed by Europlasma in 1997, and applied on industrial scale since 1998.

California based Liquipel (http://www.liquipel.com) has been a licensee of Europlasma's patented and patent pending "Nanofics" technology since 2011. Liquipel was awarded a Silver Medal at the 2012 Thomas Edison Awards using Europlasma's breakthrough, nanocoating technology platform. Liquipel obtained an exclusive retail license for the Nanofics technology in the United States and non-exclusive retail licenses in Hong Kong, Malaysia, Indonesia, and Australia. The Nanofics technology has been sub-licensed by Liquipel to LQP Asia Limited for Hong Kong, Malaysia, Indonesia, and to Vita Group for Australia.

Fung Yu Group and its partner Hydrowarriors (http://www.hydrowarriors.com) based in China currently market the Nanofics technology for handheld electronic devices under the brand name "Hydrowarriors" and have an exclusive license for the retail market in China and Macau, as well as a non- exclusive license for the retail market in Hong Kong.

Intego Capital LLC (http://www.integocapital.com) is a Delaware based technology investment firm founded in early 2012. Intego Capital currently holds exclusive licenses for Europlasma's "Nanofics" nanocoating technology in Nigeria, the Middle East (GCC and Levant countries) and North Africa region (MENA), Latin America (LATAM), Turkey, Central America, Mexico and the Caribbean. In addition, Intego Capital has a non-exclusive license in India, Bangladesh and Pakistan.  In the MENA region Intego is launching from Dubai under the Aquacoat brand name (http://www.aquacoat.co).

Europlasma's Managing Director Filip Legein comments: "as the true pioneer in nanocoating technology, we are happy to see that 15 years of intensive R&D by the Europlasma team has resulted in a growing number of markets and applications, such as air filtration products, functional textiles, medical devices, and now handheld electronics. In handheld electronic devices it has become clear that the end customer is willing to pay for additional protection against liquid damage. It will be interesting to see how fast the retail market will drive the manufacturers to adopt the technology on a wider scale. This has created a steep growth in demand which Europlasma is able to meet with a reliable technology platform, running on industrial scale of equipment."

Europlasma is expecting to announce new retail partnerships for handheld electronic devices in Europe and other regions soon. If you are a mobile operator, retailer or mobile distributor interested in our patented and patent pending Nanofics nanocoating technology, please contact our licensees directly through their websites.

If you would like to become a licensee for an available territory, or you are interested to implement the technology on a manufacturing level, please contact Mr. Filip Legein at: [email protected].

For press inquiries, please contact our marketing representative Gretel Matthys at: [email protected].

Europlasma NV - De Bruwaan 5d, 9700 Oudenaarde, Belgium - Tel +32(0)55-30-32-05 - Fax +32(0)55-31-87-53 - [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.